CD180 and systemic sclerosis: Since the function of regulatory B cells in SSc is impaired [21], and we previously found that the CD180 expression of these cells is downregulated by anti-CD180 treatment [12], we investigated whether stimulation of B cells via CD180 has different effect on IL-10 production in dcSSc and HC.